Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study - Journal of Translational Medicine

Brasil Notícia Notícia

Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study - Journal of Translational Medicine
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 BioMedCentral
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 71%

A study in the Journal of Translational Medicine suggests that low-dose risperidone in combination with sertraline is more effective for psychotic symptoms and with fewer adverse effects in first-episode drug-naïve patients with schizophrenia.

In addition, blood prolactin levels were determined in the hospital laboratory using commercially available kits.Required sample sizes for adequate power were calculated using the G*Power program. Based on a one-sided α of 0.05, a sample size of 102 evaluable patients in each treatment group was needed to identify the effect size of 0.35 at 80% power. Assuming a dropout rate of 10%, a minimum sample of 204 evaluable patients was needed.

A repeated measures multivariate analysis of variance was used to compare the efficacy of the two treatment regimens. For dependent variables, prolactin levels and symptom scores measured at 5 time points were considered as repeated measures within effects, treatment groups were considered as between effects, and age, gender, age at onset, and education were covariates. In each RM-ANOVA model, the independent variables were outcome measures over time.

Data were analyzed using PASW Statistics . Significance was set at p 0.05). In addition, there were no significant differences in PANSS scores, CGI-S, PSP, and HAMD total scores between the two groups . In addition, there was also no difference in prolactin levels between the RS and control groups .

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

BioMedCentral /  🏆 22. in UK

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Study shows that anti-PTM antibodies are often present in autoimmune mediated liver diseaseStudy shows that anti-PTM antibodies are often present in autoimmune mediated liver diseaseA recent study published in Frontiers in Medicine described anti-post-translational modification (PTM) antibodies in patients with autoimmune-mediated and cholestatic liver diseases (AILD).
Consulte Mais informação »



Render Time: 2025-03-01 12:55:05